Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleural mesothelioma

H J Wanebo, N Martini, M R Melamed

    Cancer
    |December 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Malignant pleural mesothelioma survival depends on type and treatment. Epithelial mesothelioma with combined surgery, radiation, and chemotherapy offers better outcomes, while fibrosarcomatous mesothelioma benefits from complete resection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tongue Cancer.

    Postgraduate medicine·2016
    Same author

    Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Early postoperative rising; a statistical study of hospitals complications.

    Surgery, gynecology & obstetrics·2010
    Same author

    Changing gastric cancer treatment in the United States and the pursuit of quality.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2005
    Same author

    Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2003
    Same author

    Resection for recurrent colorectal liver metastases.

    Cancer treatment and research·2002

    Area of Science:

    • Thoracic oncology
    • Pleural diseases
    • Cancer research

    Background:

    • Pleural mesothelioma is a rare but aggressive cancer.
    • Understanding survival factors is crucial for patient outcomes.
    • Historical data provides insights into treatment efficacy.

    Purpose of the Study:

    • To analyze survival rates for pleural mesothelioma patients.
    • To evaluate the impact of different treatments on survival.
    • To compare outcomes for epithelial versus fibrosarcomatous mesothelioma.

    Main Methods:

    • Retrospective review of 76 pleural mesothelioma cases (1939-1972).
    • Histological classification into epithelial and fibrosarcomatous types.
    • Analysis of treatment modalities including surgery, radiation, and chemotherapy.

    Related Experiment Videos

    Main Results:

    • Median survival for epithelial mesothelioma: 21 months (resection) vs. 8 months (radiation).
    • Median survival for fibrosarcomatous mesothelioma: 11 months (resection) vs. 9 months (radiation).
    • Advanced/recurrent disease median survival: 3-6 months; benign mesothelioma had no recurrence after resection.

    Conclusions:

    • Epithelial mesothelioma with diffuse pleural involvement has a poor prognosis.
    • Combined modality treatment (surgery, radiation, chemotherapy) improves survival for epithelial mesothelioma.
    • Complete resection offers long-term survival chances for fibrosarcomatous mesothelioma.